- Home
- VCRE vs CFBK Comparison
VCRE vs CFBK Comparison
Compare VCRE & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | VCRE | CFBK |
|---|---|---|
| Founded | 2000 | 1892 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | | Major Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.7M | 219.7M |
| IPO Year | 2026 | 2005 |
Fundamental Metrics
Financial Performance| Metric | VCRE | CFBK |
|---|---|---|
| Price | $9.44 | $35.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $29.97 | N/A |
| AVG Volume (30 Days) | 20.2K | ★ 31.3K |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 1.03% |
| EPS Growth | N/A | ★ 30.58 |
| EPS | N/A | ★ 1.67 |
| Revenue | N/A | N/A |
| Revenue This Year | $101.29 | $7.47 |
| Revenue Next Year | $481.15 | $12.52 |
| P/E Ratio | ★ N/A | $21.02 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.88 | $22.10 |
| 52 Week High | $14.01 | $38.11 |
Technical Indicators
Market Signals| Indicator | VCRE | CFBK |
|---|---|---|
| Relative Strength Index (RSI) | 45.55 | 60.54 |
| Support Level | $8.70 | $33.51 |
| Resistance Level | $9.64 | $35.23 |
| Average True Range (ATR) | 0.51 | 0.78 |
| MACD | 0.07 | 0.14 |
| Stochastic Oscillator | 19.38 | 82.87 |
Price Performance
Historical ComparisonAbout VCRE Vicore Pharma Holding AB American Depositary Shares
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans, and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.